Donald Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive
US President Donald Trump on Tuesday announced the final stage of his pharmaceutical tariff plan, under which imported generic medicines will continue to enter the US without duties until August 1, 2028.
Trump Plans 200% Tariff on Generic Drugs
- Donald Trump reveals 200% tariff plan for generic medicines. Will India exports be hit? The Indian Express —
- Pharma stocks bleed after Trump announces up to 200% tariff on generic drugs; Aurobindo, Sun Pharma & Cipla slide over 3% Times Of India —
- Trump outlines plans for up to 200% tariffs on generic drug imports starting in 2028 Seeking Alpha —
- Trump Plans 100% Tariff on Generic Drugs From 2028 | Insight with Haslinda Amin 7/22/2026 📹 Bloomberg — · 47min
- Trump drops tariff bombshell on generic drugs with 200% threat The Independent —